Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tempus

How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma

Imagine you stepped into the dimly lit hospital meeting room to pitch a new cancer‑diagnostic deal. You flick through slides powered by Palantir Technologies Inc.'s (NASDAQ:PLTR) Foundry platform, showcasing data transparency and precision that would make legacy pharma pipelines look prehistoric.

Benzinga

Tempus AI Stock Is Rising Wednesday: What's Happening?

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday after the company announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ejection fraction software.

Benzinga

Cathie Wood Bets Another $1 Million On Tempus AI Despite Jim Cramer's Doubts, Dumps Crypto Stocks As Bitcoin Hits Fresh New Highs

On Thursday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:TEM), Coinbase Global Inc. (NASDAQ:COIN), Robinhood Markets Inc. (NASDAQ:HOOD), and Block Inc. (NYSE:XYZ).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist'

When it comes to artificial intelligence stocks, there are multiple that are found in the various portfolios of Ark Funds, led by Cathie Wood.

Benzinga

Cathie Wood Dumps Jack Dorsey's Block As Bitcoin Flirts With All-Time Highs, Bets $8.8 million On Tempus AI

On Wednesday, the Cathie Wood-led Ark Invest made a significant move by purchasing a substantial number of shares in Tempus AI Inc. (NASDAQ:TEM) and selling shares of Block Inc. (NYSE:XYZ). The trades were executed through the ARKG and ARKK ETFs.

Benzinga

Short Sellers Are Taking Aim at Buy-Rated Tempus AI. Should You Buy TEM Stock Here?

Tempus AI stock fell over 19% after Spruce Point Capital released a short report. Can TEM stock recover?

Barchart

Tempus AI Stock: Time to Double Down or Cut and Run?

Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now?

Barchart

Conflicting Signals: Tempus AI's Stock Market Rally

Tempus AI's stock has soared on completed acquisitions and product launches, yet mixed analyst sentiment signals a need for careful investor review.

MarketBeat

Cathie Wood Just Doubled Down on This AI Stock. Should You?

The stock is one of the renowned investor’s top holdings.

Barchart

Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound

Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024.

MarketBeat

Tempus AI: A Game-Changer in AI-Powered Healthcare

TEM surged 35% on Tuesday, fueled by the launch of its AI-powered health app Olivia and news of Nancy Pelosi's disclosed call option position in the stock.

MarketBeat

The Tempus, Northumberland hotel review

Annabel Grossman checks in

The Independent UK

Tempus AI: A Potential Double-Bagger After Recent Pullback

AI healthcare stock Tempus AI has seen its value fall off a cliff recently. However, Wall Street remains bullish, seeing significant upside in the shares.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

1 AI Stock Cathie Wood Is Buying Instead of Tesla

Cathie Wood is shifting away from Tesla, zeroing in on an AI-driven healthcare firm that is revolutionizing precision medicine and advanced diagnostics.

Barchart

Should You Follow Cathie Wood Into This AI Diagnostics Stock?

This AI diagnostics stock is a holding in Wood's ARKK and ARKG ETFs.

Fortune

The IPO market is gaining steam. Who might list later this year?

Big debuts from Reddit and Astera Labs are raising hope the IPO market has finally rebounded. But it’s still not the soaring, go-go days of 2021.

StockNews.com

3 Pharma Stocks to Buy in 2023 and Hold for Decades

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….

Get all your
news in one place.

100’s of premium titles.
One news app.

Chronicle Live

Four Northumberland openings listed as Time Out's best things to do in 2023

The county is in for another big year of tourism if the popular travel and culture magazine's list is anything to go by!

Birmingham Post

Doxford Group set to open new Northumberland boutique hotel, bar and restaurant

The Tempus will have 15 rooms and bistro-style dining and cocktails when it opens next year

Chronicle Live

First look at Alice in Wonderland inspired hotel, bar and restaurant opening in Northumberland

The Tempus will be a sister venue to quirky boutique hotel Charlton Hall when it opens next spring

The Guardian - UK

Pub firms were lockdown losers but can adapt to tough trading conditions

It’s possible much of current uncertainty is already priced in to recovery of well-run companies like M&B and Marston’s

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Palantir Technologies Inc

217 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.